In-vitro and in-vivo evidence of dose-dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules
- 1 April 2008
- journal article
- research article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 14 (4), 350-355
- https://doi.org/10.1111/j.1469-0691.2007.01917.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Bioactive compounds in cranberries and their role in prevention of urinary tract infectionsMolecular Nutrition & Food Research, 2007
- Virulence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M β-lactamasesClinical Microbiology & Infection, 2006
- Role of cranberry juice on molecular‐scale surface characteristics and adhesion behavior of Escherichia coliBiotechnology & Bioengineering, 2005
- A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activityPhytochemistry, 2005
- The worm has turned – microbial virulence modeled in Caenorhabditis elegansTrends in Microbiology, 2005
- Cranberry Juice and Urinary Tract InfectionClinical Infectious Diseases, 2004
- Growing Group of Extended-Spectrum β-Lactamases: the CTX-M EnzymesAntimicrobial Agents and Chemotherapy, 2004
- Cranberry Juice and Adhesion of Antibiotic-Resistant UropathogensJAMA, 2002
- Risk Factors for Antibiotic-Resistant Escherichia coli Isolated from Hospitalized Patients with Urinary Tract Infections: a Prospective StudyJournal of Clinical Microbiology, 2001
- Inhibition of the Adherence of P-FimbriatedEscherichia colito Uroepithelial-Cell Surfaces by Proanthocyanidin Extracts from CranberriesNew England Journal of Medicine, 1998